Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Stability of personality traits over a five-year period in Swedish patients with schizophrenia spectrum disorder and nonpsychotic individuals: a study using the Swedish universities scales of personality

  • 1Email author,
  • 1,
  • 2,
  • 1, 3, 4 and
  • 1, 3
BMC Psychiatry201919:109

https://doi.org/10.1186/s12888-019-2086-7

  • Received: 19 March 2019
  • Accepted: 19 March 2019
  • Published:

The original article was published in BMC Psychiatry 2018 18:54

Correction to: BMC Psychiatry

https://doi.org/10.1186/s12888-018-1617-y

After publication of the original article [1], it was brought to our attention that some of the numbers in Table 3 were incorrectly reported due to data entry errors. The corrected Table 3 can be found below - modified values are marked with bold. We apologize for the inconvenience this may have caused.
Table 3

Swedish universities Scales of Personality (SSP) raw scores (mean [standard deviation]) and 95% confidence interval (CI) of the difference between baseline and follow-up in patients with psychotic illness and non-psychotic controls

  

N

Somatic Trait Anxiety

Psychic Trait Anxiety

Stress Susceptibility

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

36

2.08 (0.48)

2.13 (0.53)

−0.25 – 0.15

2.45 (0.62)

2.36 (0.61)

−0.09 – 0.27

2.46 (0.55)

2.47 (0.53)

−0.19 – 0.16

Control

76

1.58 (0.46)

1.55 (0.45)

−0.06 – 0.12

1.66 (0.50)

1.48 (0.39)

0.11–0.26

1.87 (0.47)

1.82 (0.44)

−0.05 – 0.14

ALL

Men

75

1.68 (0.48)

1.71 (0.56)

−0.14 – 0.08

1.92 (0.68)

1.79 (0.66)

0.04–0.22

2.06 (0.61)

2.02 (0.58)

−0.06 – 0.14

Women

37

1.85 (0.58)

1.78 (0.53)

−0.08 – 0.21

1.90 (0.60)

1.70 (0.55)

0.07–0.34

2.04 (0.46)

2.05 (0.53)

−0.17 – 0.16

PATIENT

Men

28

2.05 (0.39)

2.19 (0.51)

−0.39 – 0.09

2.47 (0.60)

2.43 (0.52)

−0.17 – 0.24

2.48 (0.60)

2.52 (0.46)

−0.24 – 0.17

Women

8

2.21 (0.71)

1.93 (0.57)

0.02–0.55

2.38 (0.71)

2.09 (0.84)

−0.17 – 0.74

2.36 (0.38)

2.30 (0.76)

−0.40 – 0.51

CONTROL

Men

47

1.47 (0.39)

1.43 (0.36)

−0.06 – 0.14

1.60 (0.49)

1.41 (0.37)

0.10–0.28

1.81 (0.47)

1.72 (0.41)

−0.02 – 0.20

Women

29

1.75 (0.51)

1.74 (0.52)

−0.16 – 0.18

1.77 (0.51)

1.59 (0.40)

0.04–0.33

1.96 (0.45)

1.98 (0.44)

−0.21 – 0.17

  

Lack of Assertiveness

Impulsiveness

Adventure Seeking

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.50 (0.64)

2.43 (0.62)

−0.13 – 0.28

2.33 (0.52)

2.25 (0.51)

−0.07 – 0.23

2.50 (0.58)

2.38 (0.61)

−0.04 – 0.29

Control

1.91 (0.40)

1.87 (0.43)

−0.04 – 0.11

2.30 (0.46)

2.19 (0.47)

0.02–0.20

2.53 (0.52)

2.39 (0.51)

0.07–0.22

ALL

Men

2.12 (0.58)

2.07 (0.61)

−0.06 – 0.16

2.23 (0.47)

2.15 (0.47)

−0.01 – 0.17

2.57 (0.58)

2.42 (0.56)

0.06–0.25

Women

2.06 (0.54)

2.02 (0.44)

− 0.07 – 0.15

2.48 (0.45)

2.34 (0.49)

0.01–0.28

2.42 (0.43)

2.33 (0.50)

− 0.01 – 0.21

PATIENT

Men

2.55 (0.59)

2.48 (0.63)

−0.18 – 0.33

2.28 (0.51)

2.21 (0.52)

−0.12 – 0.24

2.52 (0.62)

2.34 (0.65)

−0.02 – 0.38

Women

2.34 (0.83)

2.27 (0.59)

−0.21 – 0.35

2.52 (0.51)

2.38 (0.48)

−0.22 – 0.49

2.46 (0.39)

2.54 (0.46)

−0.33 – 0.19

CONTROL

Men

1.86 (0.40)

1.83 (0.45)

−0.06 – 0.13

2.19 (0.44)

2.11 (0.44)

−0.02 – 0.20

2.61 (0.55)

2.47 (0.51)

0.04–0.24

Women

1.99 (0.41)

1.95 (0.37)

−0.09 – 0.16

2.47 (0.44)

2.33 (0.50)

−0.00 – 0.30

2.41 (0.44)

2.27 (0.50)

0.02–0.27

  

Detachment

Social Desirability

Embitterment

Baseline

Follow-up

CI

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.33 (0.63)

2.31 (0.52)

−0.14 – 0.17

2.77 (0.53)

2.83 (0.45)

−0.24 – 0.13

2.23 (0.50)

2.22 (0.55)

−0.15 – 0.17

Control

1.90 (0.43)

1.85 (0.43)

−0.02 – 0.12

2.83 (0.37)

2.92 (0.35)

−0.15 - -0.03

1.60 (0.41)

1.47 (0.40)

0.05–0.20

ALL

Men

2.16 (0.54)

2.13 (0.49)

−0.05 – 0.12

2.80 (0.43)

2.88 (0.39)

−0.16 – 0.00

1.82 (0.52)

1.72 (0.59)

0.01–0.20

Women

1.78 (0.45)

1.74 (0.42)

−0.09 – 0.18

2.82 (0.42)

2.90 (0.38)

−0.21 – 0.06

1.75 (0.56)

1.69 (0.54)

−0.06 – 0.18

PATIENT

Men

2.41 (0.65)

2.39 (0.50)

−0.14 – 0.20

2.82 (0.56)

2.80 (0.46)

−0.18 – 0.21

2.23 (0.44)

2.23 (0.57)

−0.20 – 0.20

Women

2.04 (0.52)

2.05 (0.53)

−0.51 – 0.48

2.61 (0.42)

2.91 (0.44)

−0.87 – 0.26

2.23 (0.69)

2.17 (0.51)

−0.22 – 0.34

CONTROL

Men

2.02 (0.41)

1.97 (0.42)

−0.05 – 0.13

2.79 (0.34)

2.93 (0.34)

−0.21 - − 0.07

1.58 (0.39)

1.42 (0.34)

0.08–0.25

Women

1.71 (0.41)

1.65 (0.35)

-0.07 – 0.20

2.88 (0.41)

2.90 (0.36)

−0.12 – 0.09

1.62 (0.45)

1.56 (0.47)

−0.08 – 0.20

  

Trait Irritability

Mistrust

  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.35 (0.57)

2.13 (0.57)

0.03–0.40

2.26 (0.58)

2.26 (0.52)

− 0.13 – 0.15

  

Control

2.21 (0.48)

2.03 (0.49)

0.09–0.26

1.75 (0.50)

1.60 (0.47)

0.06–0.24

  

ALL

Men

2.26 (0.49)

2.04 (0.53)

0.12–0.31

1.97 (0.56)

1.86 (0.57)

0.02–0.21

  

Women

2.24 (0.55)

2.11 (0.50)

−0.03 – 0.29

1.81 (0.59)

1.72 (0.58)

−0.03 – 0.21

  

PATIENT

Men

2.36 (0.56)

2.16 (0.53)

0.01–0.38

2.28 (0.58)

2.25 (0.53)

−0.14 – 0.21

  

Women

2.32 (0.66)

2.04 (0.74)

−0.37 – 0.94

2.20 (0.62)

2.29 (0.55)

−0.24 – 0.07

  

CONTROL

Men

2.20 (0.45)

1.97 (0.51)

0.11–0.34

1.79 (0.47)

1.62 (0.47)

0.05–0.28

  

Women

2.22 (0.53)

2.13 (0.43)

−0.05 – 0.22

1.70 (0.54)

1.56 (0.49)

−0.01 -0.29

  
  

Verbal Trait Aggression

Physical Trait Aggression

  

Baseline

Follow-up

CI

Baseline

Follow-up

CI

ALL

Patient

2.01 (0.64)

2.00 (0.55)

−0.19 – 0.20

1.71 (0.57)

1.84 (0.60)

−0.31 – 0.07

  

Control

2.15 (0.47)

1.96 (0.46)

0.10–0.28

1.93 (0.57)

1.67 (0.54)

0.17–0.35

  

ALL

Men

2.12 (0.53)

2.02 (0.52)

−0.01 – 0.21

1.92 (0.60)

1.81 (0.59)

0.00–0.23

  

Women

2.07 (0.55)

1.88 (0.43)

0.04–0.33

1.73 (0.53)

1.55 (0.46)

0.01–0.33

  

PATIENT

Men

2.03 (0.62)

2.07 (0.58)

−0.26 – 0.18

1.76 (0.59)

1.86 (0.66)

−0.33 – 0.13

  

Women

1.95 (0.74)

1.79 (0.38)

−0.37 – 0.69

1.54 (0.47)

1.74 (0.39)

−0.57 – 0.16

  

CONTROL

Men

2.18 (0.46)

2.00 (0.48)

0.07–0.31

2.02 (0.58)

1.78 (0.55)

0.14–0.35

  

Women

2.10 (0.50)

1.91 (0.44)

0.04–0.34

1.78 (0.54)

1.50 (0.47)

0.11–0.44

  

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Human Brain Informatics (HUBIN), Department of Clinical Neuroscience, Centre for Psychiatric Research, Psychiatry Section, Karolinska Institutet and Hospital, Stockholm, Sweden
(2)
Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
(3)
NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, Psychiatry Section, University of Oslo, Oslo, Norway
(4)
Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway

Reference

  1. Fagerberg, et al. Stability of personality traits over a five-year period in Swedish patients with schizophrenia spectrum disorder and nonpsychotic individuals: a study using the Swedish universities scales of personality. BMC Psychiatry. 2018;18:54. https://doi.org/10.1186/s12888-018-1617-y.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement